Journal Home
Search for

Volume 135, Issue 6, Pages 853-857 (December 2006)


View previous. 12 of 50 View next.

Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats

Ande Bao, PhDaCorresponding Author Informationemail address, William T. Phillips, MDb, Beth Goins, PhDb, Howard S. McGuff, DDSc, Xiangpeng Zheng, MDd, F. Ross Woolley, PhDb, Mohan Natarajan, PhDa, Cristina Santoyo, MSb, Frank R. Miller, MDa, Randal A. Otto, MDa1

Objective

To develop and characterize a new head and neck cancer animal model.

Study design

A human head and neck squamous cell carcinoma (HNSCC) xenograft model in nude rats was established via subcutaneous inoculation of a human-origin HNSCC cell line, SCC-4. The tumor was evaluated for growth characteristics, pathologic features by hematoxylin-eosin (HE) staining, and immunohistochemistry of epidermal growth factor receptor (EGFR). 2-[18F] fluoro-2-deoxy-D-glucose (18F-FDG) positron emission tomography (PET) imaging characteristics were studied too.

Results

A new HNSCC animal model was successfully established. Tumor sizes reached about 1 cm3 on day 15 after tumor cell inoculation. HE staining pathology has confirmed that this tumor is a typical SCC. EGFR immunohistochemistry demonstrated this tumor model to be strongly EGFR positive. 18F-FDG PET study has shown that 18F-FDG accumulated in tumors.

Conclusions

This study has demonstrated that this tumor model is an appropriate HNSCC tumor model for animal studies on HNSCC.

a Department of Otolaryngology–Head and Neck Surgery; University of Texas Health Science Center at San Antonio, San Antonio, Texas

b Department of Radiology; University of Texas Health Science Center at San Antonio, San Antonio, Texas

c Department of Pathology; University of Texas Health Science Center at San Antonio, San Antonio, Texas

d Department of Radiation Oncology; University of Texas Health Science Center at San Antonio, San Antonio, Texas

Corresponding Author InformationReprint requests: Ande Bao, PhD, University of Texas Health Science Center at San Antonio, Department of Otolaryngology–Head and Neck Surgery, 7703 Floyd Curl Drive, San Antonio, TX 78229-3900.

1 Randal Otto, MD, is a consultant for Nanospectra Biosciences and Aventis, and is a speaker for Bayer.

PII: S0194-5998(06)02780-X

doi:10.1016/j.otohns.2006.06.1257


View previous. 12 of 50 View next.